Driehaus Capital Management LLC Eye Point Pharmaceuticals, Inc. Transaction History

Driehaus Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$8.67 - $14.11 $4.48 Million - $7.28 Million	-516,234 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$10.18 - $18.4 $2.39 Million - $4.33 Million	-235,207 Reduced 31.3%	516,234 $6.32 Million
Q3 2021 Nov 15, 2021	SELL	$7.51 - $11.72 $52,434 - $81,829	-6,982 Reduced 0.92%	751,441 $7.83 Million
Q2 2021 Aug 16, 2021	SELL	$8.69 - $11.08 $455,295 - $580,514	-52,393 Reduced 6.46%	758,423 $6.82 Million
Q1 2021 May 17, 2021	BUY	$8.89 - $14.92 $7.21 Million - $12.1 Million	810,816 New	810,816 $8.24 Million

150

58M

177K

263K

Ticker EYPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,072,200
Market Cap $357M
Description
EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...

Get notified when there are updates to the investment portfolio of Driehaus Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Driehaus Capital Management LLC with notifications on news.